English
Polski
Español
українська
New lipid-lowering drugs in hypercholesterolemia
Which patients with hypercholesterolemia may be offered new lipid-lowering drugs, including proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors?
2018-01-11
Which patients with hypercholesterolemia may be offered new lipid-lowering drugs, including proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors?
What are the absolute contraindications to the administration of acetylsalicylic acid in patients with suspected acute coronary syndrome during prehospital care?
Are there any differences in the treatment of patients with myocardial infarction after noncardiac surgery compared to other patients with myocardial infraction? How is the management influenced by a history of coronary artery disease and previous percutaneous coronary intervention?
What is the threshold for low-density lipoprotein cholesterol levels for starting statins in otherwise healthy middle-aged men or women?
What are the tolerance and adverse effects of proprotein convertase subtilisin/kexin type 9 inhibitors?
How should we prepare for a major surgery a patient without cardiovascular disease but at a high cardiovascular risk?
How should we prepare a patient with cardiovascular disease for a major surgery? What diagnostic procedures should we perform? Should we start a new treatment or change the already used drugs or their doses?
Does every patient with a BP >180/100 mm Hg require urgent treatment and hospitalization? What antihypertensive agents should be used in general practice? How to quickly lower BP?
How was non-ST-segment elevation acute coronary syndrome diagnosed in 2016?
Is moderate alcohol intake permitted in patients with cardiovascular diseases?
